Thursday, June 11, 2026
πŸ‡ΊπŸ‡Έ FDA

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1169 of 1,261

  1. US 6630121

    Supercritical fluid-assisted nebulization and bubble drying

    The Regents of the University of Colorado Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  2. US 6630124

    Combination therapy with VIP antagonist

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  3. US 6630170

    Mesoporous compositions and method of preparation

    The Board of Regents of the University of Texas System Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  4. US 6630169

    Particulate delivery systems and methods of use

    Nektar Therapeutics Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  5. US 6630344

    Diminishing viral gene expression by promoter replacement

    Texas Systems, University of the Board of the Regents Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  6. US 6630144

    Monoclonal antibodies to Ebola glycoprotein

    The United States of America as represented by the Secretary of the Army Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  7. US 6629970

    Method of restoring endothelium of cornea

    Obschestvo S Ogranichennoi Otvetstvennostiju ΓƒΒ’Γ’β€šΒ¬Γ…β€œNauchno-Experimentalnoe Proizvodstvo Mikrokhirurgia GlazaΓƒΒ’Γ’β€šΒ¬Γ‚Β Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  8. US 6630167

    Hyaluronic acid anti-adhesion barrier

    United States Surgical Corporation Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  9. US 6630447

    Peptide inhibitors of LFA-1/ICAM-1 interaction

    The Regents of the University of New Mexico Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  10. US 6630514

    Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  11. US 6630507

    Cannabinoids as antioxidants and neuroprotectants

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  12. US 6630484

    6-and 7-substituted analogs of swainsonine their preparation and therapeutic use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  13. US 6630516

    Methods and compositions for preventing and treating chronological aging in human skin

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  14. US 6630572

    Thrombin derived polypeptides: compositions and methods for use

    The Board of Regents of the University of Texas System Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  15. US 6630464

    Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Oct 7, 2003 Β· Expires Oct 2, 2023

    expired

  16. US 2003185759

    Ultrasound contrast agents and methods of making and using them

    BRACCO INT BV [NL] Β· Granted Oct 2, 2003 Β· Expires Sep 27, 2023

    expired

  17. US 6627630

    Condensed pyridazine derivatives, their production and use

    Takeda Chemical Industries Ltd. Β· Granted Sep 30, 2003 Β· Expires Sep 25, 2023

    expired

  18. US 6627651

    Cyclic compounds and uses thereof

    Takeda Chemical Industries Ltd. Β· Granted Sep 30, 2003 Β· Expires Sep 25, 2023

    expired

  19. US 6627645

    Muscarinic agonists

    ACADIA Pharmaceuticals Inc. Β· Granted Sep 30, 2003 Β· Expires Sep 25, 2023

    expired

  20. US 6627415

    TIE-2 ligands, methods of making and uses thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted Sep 30, 2003 Β· Expires Sep 25, 2023

    expired

  21. US 6627189

    Inhibition of cellular proliferation using ras antisense molecules

    The Board of Regents of the University of Texas System Β· Granted Sep 30, 2003 Β· Expires Sep 25, 2023

    expired

  22. US 6627615

    Methods and compositions for in vivo gene therapy

    The Regents of the University of California Β· Granted Sep 30, 2003 Β· Expires Sep 25, 2023

    expired

  23. US 6627619

    Antisense compositions for detecting and inhibiting telomerase reverse transcriptase

    The Regents of the University of Technology Office of Technology Transfer Β· Granted Sep 30, 2003 Β· Expires Sep 25, 2023

    expired

  24. US 6627641

    Antimalarial naphthylisoquinoline alkaloids and pharmaceutical compositions and medical uses thereof

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Sep 30, 2003 Β· Expires Sep 25, 2023

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.